These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 7291211)

  • 1. [A general method of simulating blood levels from dissolution data. 1. Single dose].
    Gueurten D; Jaminet F
    Pharm Acta Helv; 1981; 56(9-10):276-80. PubMed ID: 7291211
    [No Abstract]   [Full Text] [Related]  

  • 2. Simple transformation method for predicting plasma drug profiles from dissolution rates.
    Vaughan DP; Leach RH
    J Pharm Sci; 1976 Apr; 65(4):601-3. PubMed ID: 1271266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of human pharmacokinetics--gastrointestinal absorption.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [General method for the simulation of blood levels from dissolution data: II. Multiple doses].
    Gueurten D; Jaminet F
    Pharm Acta Helv; 1981; 56(11):314-9. PubMed ID: 7312886
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of in vitro dissolution data to predict plasma drug profiles.
    Aarons LJ; Rowland M
    J Pharm Sci; 1977 Sep; 66(9):1359-62. PubMed ID: 903888
    [No Abstract]   [Full Text] [Related]  

  • 6. A stochastic differential equation model for drug dissolution and its parameters.
    Lánský P; Lánská V; Weiss M
    J Control Release; 2004 Nov; 100(2):267-74. PubMed ID: 15544874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of simulation to develop multiple-dose regimens for drugs exhibiting nonlinear elimination kinetics.
    Hepler CD; Prince RA
    Am J Hosp Pharm; 1980 Dec; 37(12):1631-5. PubMed ID: 7446538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new approach to modelling the relationship between in vitro and in vivo drug dissolution/absorption.
    Dunne A; O'Hara T; Devane J
    Stat Med; 1999 Jul; 18(14):1865-76; discussion 1877. PubMed ID: 10407257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is bicarbonate buffer suitable as a dissolution medium?
    Boni JE; Brickl RS; Dressman J
    J Pharm Pharmacol; 2007 Oct; 59(10):1375-82. PubMed ID: 17910812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An algebraic model for blood concentrations.
    Tauber S
    Res Commun Chem Pathol Pharmacol; 1980 Dec; 30(3):409-17. PubMed ID: 7255858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds.
    Vertzoni M; Dressman J; Butler J; Hempenstall J; Reppas C
    Eur J Pharm Biopharm; 2005 Aug; 60(3):413-7. PubMed ID: 15893920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probability of passing dissolution acceptance criteria for an immediate release tablet.
    Dumont ML; Berry MR; Nickerson B
    J Pharm Biomed Anal; 2007 May; 44(1):79-84. PubMed ID: 17379465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport function of the blood. Pharmacological studies using radioisotopes.
    Cohen Y
    J Nucl Biol Med; 1968; 12(1):26-34. PubMed ID: 5699980
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of a programmable calculator for the prediction of drug serum levels according to the two-compartment open model.
    Messori A; Donati-Cori G; Tendi E
    Boll Chim Farm; 1982 Jul; 121(7):340-6. PubMed ID: 7150442
    [No Abstract]   [Full Text] [Related]  

  • 15. Method for screening of solid dispersion formulations of low-solubility compounds--miniaturization and automation of solvent casting and dissolution testing.
    Shanbhag A; Rabel S; Nauka E; Casadevall G; Shivanand P; Eichenbaum G; Mansky P
    Int J Pharm; 2008 Mar; 351(1-2):209-18. PubMed ID: 18054181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of drug dissolution profiles from tablets using NIR diffuse reflectance spectroscopy: a rapid and nondestructive method.
    Freitas MP; Sabadin A; Silva LM; Giannotti FM; do Couto DA; Tonhi E; Medeiros RS; Coco GL; Russo VF; Martins JA
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):17-21. PubMed ID: 15935597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N; de Matas M; Gavan PT; York P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory aspects of drug dissolution from a European perspective.
    Graffner C
    Eur J Pharm Sci; 2006 Nov; 29(3-4):288-93. PubMed ID: 16950606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
    Kortejärvi H; Urtti A; Yliperttula M
    Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using pharmacokinetics in drug therapy. VI: Comparing methods for dealing with nonlinear drugs like phenytoin.
    Schumacher GE
    Am J Hosp Pharm; 1980 Jan; 37(1):128-32. PubMed ID: 7361770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.